The Hematology Diagnostics Market was valued at USD 3.85 billion in 2023 and is projected to reach USD 6.86 billion by 2032, growing at a CAGR of 6.64% during the forecast period 2024-2032. This growth is driven by the increasing prevalence of blood disorders, advancements in hematology testing technologies, and the rising adoption of automated diagnostic...